121 related articles for article (PubMed ID: 3784571)
1. Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat.
Danesi R; Del Tacca M; Soldani G
J Pharmacol Methods; 1986 Nov; 16(3):251-9. PubMed ID: 3784571
[TBL] [Abstract][Full Text] [Related]
2. The influence of amrinone on cardiac toxicity induced by adriamycin in rats.
Bernardini C; Del Tacca M; Danesi R; Della Torre P
Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):243-53. PubMed ID: 3789887
[TBL] [Abstract][Full Text] [Related]
3. General and cardiac toxicity of adriamycinol in rats.
Danesi R; Del Tacca M; Della Torre P; Bernardini C
Anticancer Res; 1986; 6(5):967-72. PubMed ID: 3800337
[TBL] [Abstract][Full Text] [Related]
4. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
Zbinden G; Brändle E
Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
[TBL] [Abstract][Full Text] [Related]
5. Might adriamycinol contribute to adriamycin-induced cardiotoxicity?
Del Tacca M; Danesi R; Ducci M; Bernardini C; Romanini A
Pharmacol Res Commun; 1985 Nov; 17(11):1073-84. PubMed ID: 4089011
[TBL] [Abstract][Full Text] [Related]
6. Toxicological evaluation of imipramine in combination with adriamycin and strophanthin.
Zbinden G; Elsner J; Bolliger H
Agents Actions; 1977 Sep; 7(3):341-6. PubMed ID: 596318
[TBL] [Abstract][Full Text] [Related]
7. Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.
Pinna A; Agen C; Di Paolo A; Innocenti F; Nardini D; Danesi R; Del Tacca M
J Environ Pathol Toxicol Oncol; 1994; 13(1):25-31. PubMed ID: 7823290
[TBL] [Abstract][Full Text] [Related]
8. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.
Hazari MS; Haykal-Coates N; Winsett DW; Costa DL; Farraj AK
Toxicol Sci; 2009 Jul; 110(1):224-34. PubMed ID: 19407338
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.
Jensen RA; Acton EM; Peters JH
Cancer Res; 1984 Sep; 44(9):4030-9. PubMed ID: 6744318
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.
Hirano S; Wakazono K; Agata N; Iguchi H; Tone H
Drugs Exp Clin Res; 1994; 20(4):153-60. PubMed ID: 7813387
[TBL] [Abstract][Full Text] [Related]
11. Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.
Agen C; Bernardini N; Danesi R; Della Torre P; Costa M; Del Tacca M
Cancer Chemother Pharmacol; 1992; 30(2):95-9. PubMed ID: 1600601
[TBL] [Abstract][Full Text] [Related]
12. 3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity.
Danesi R; Agen C; Grandi M; Nardini V; Bevilacqua G; Del Tacca M
Eur J Cancer; 1993; 29A(11):1560-5. PubMed ID: 8217363
[TBL] [Abstract][Full Text] [Related]
13. Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat.
Cirillo R; Sacco G; Venturella S; Brightwell J; Giachetti A; Manzini S
J Cardiovasc Pharmacol; 2000 Jan; 35(1):100-8. PubMed ID: 10630739
[TBL] [Abstract][Full Text] [Related]
14. The rat model in the comparative evaluation of anthracyclines cardiotoxicity.
Lanza E; Rozza A; Favalli L; Monti E; Poggi P; Villani F
Tumori; 1989 Dec; 75(6):533-6. PubMed ID: 2617699
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin (adriamycin)-induced cardiotoxicity in turkey poults: an animal model.
Czarnecki CM
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 83(1):53-60. PubMed ID: 2869907
[TBL] [Abstract][Full Text] [Related]
16. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
[TBL] [Abstract][Full Text] [Related]
17. Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart.
Bernardini N; Danesi R; Bernardini MC; Del Tacca M
Experientia; 1988 Dec; 44(11-12):1000-2. PubMed ID: 3197802
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects.
Jensen RA; Acton EM; Peters JH
J Cardiovasc Pharmacol; 1984; 6(1):186-200. PubMed ID: 6199603
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicin.
Danesi R; Bernardini N; Agen C; Costa M; Macchiarini P; Della Torre P; Del Tacca M
Toxicology; 1991; 70(2):243-53. PubMed ID: 1763418
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats.
Danesi R; Bernardini N; Marchetti A; Bernardini M; Del Tacca M
Cancer Chemother Pharmacol; 1990; 25(5):326-32. PubMed ID: 2306792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
